GENE logo

Genetic Technologies Limited (GENE) Long Term Liabilities

Annual Total Long Term Liabilities

$107.40 K
-$145.20 K-57.48%

01 June 2024

GENE Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$107.40 K
-$51.30 K-32.33%

01 June 2024

GENE Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GENE Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-57.5%-57.5%
3 y3 years+329.6%+329.6%
5 y5 years+10000.0%+10000.0%

GENE Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-72.1%+329.6%-72.1%+329.6%
5 y5 years-72.1%>+9999.0%-72.1%>+9999.0%
alltimeall time-95.6%-97.8%>+9999.0%

Genetic Technologies Limited Long Term Liabilities History

DateAnnualQuarterly
June 2024
$107.40 K(-57.5%)
$107.40 K(-32.3%)
Dec 2023
-
$158.70 K(-37.2%)
June 2023
$252.60 K(-34.3%)
$252.60 K(-14.2%)
Dec 2022
-
$294.40 K(-23.4%)
June 2022
$384.50 K(+1438.0%)
$384.50 K(+65.7%)
Dec 2021
-
$232.00 K(+828.0%)
June 2021
$25.00 K(-85.0%)
$25.00 K(-73.2%)
Dec 2020
-
$93.20 K(-44.1%)
June 2020
$166.80 K(>+9900.0%)
$166.80 K(+72.3%)
Dec 2019
-
$96.80 K(>+9900.0%)
June 2019
$600.00(-76.0%)
$600.00(-99.1%)
Dec 2018
-
$64.70 K(+2488.0%)
June 2018
$2500.00(-94.9%)
$2500.00(-89.5%)
Dec 2017
-
$23.90 K(-51.3%)
June 2017
$49.10 K(-11.5%)
$49.10 K(+1.2%)
Dec 2016
-
$48.50 K(-12.6%)
June 2016
$55.50 K(+186.1%)
$55.50 K(-6.1%)
Dec 2015
-
$59.10 K(+204.6%)
June 2015
$19.40 K(-99.2%)
$19.40 K(-98.5%)
Dec 2014
-
$1.26 M(-48.3%)
June 2014
$2.43 M
$2.43 M(-49.8%)
DateAnnualQuarterly
Dec 2013
-
$4.84 M(+5325.0%)
June 2013
$89.30 K(-18.0%)
$89.30 K(-22.3%)
Dec 2012
-
$115.00 K(+5.6%)
June 2012
$108.90 K(+23.2%)
$108.90 K(+3.3%)
Dec 2011
-
$105.40 K(+19.2%)
June 2011
$88.40 K(+26.8%)
$88.40 K(-52.2%)
Dec 2010
-
$184.80 K(+165.1%)
June 2010
$69.70 K(+0.1%)
$69.70 K(-21.9%)
Dec 2009
-
$89.20 K(+28.2%)
June 2009
$69.60 K(-72.3%)
$69.60 K(-74.8%)
Dec 2008
-
$276.30 K(+9.9%)
June 2008
$251.40 K(+204.4%)
$251.40 K(+217.0%)
Dec 2007
-
$79.30 K(-4.0%)
June 2007
$82.60 K(-90.9%)
$82.60 K(-65.8%)
Dec 2006
-
$241.60 K(-73.5%)
June 2006
$912.00 K(-27.1%)
$912.00 K(+83.0%)
Dec 2005
-
$498.40 K(-60.2%)
June 2005
$1.25 M(+158.0%)
$1.25 M(+128.8%)
Dec 2004
-
$546.90 K
June 2004
$485.00 K(+3.4%)
-
June 2003
$468.90 K(>+9900.0%)
-
June 2000
$0.00
-

FAQ

  • What is Genetic Technologies Limited annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Genetic Technologies Limited?
  • What is Genetic Technologies Limited annual total long term liabilities year-on-year change?
  • What is Genetic Technologies Limited quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Genetic Technologies Limited?
  • What is Genetic Technologies Limited quarterly long term liabilities year-on-year change?

What is Genetic Technologies Limited annual total long term liabilities?

The current annual total long term liabilities of GENE is $107.40 K

What is the all time high annual total long term liabilities for Genetic Technologies Limited?

Genetic Technologies Limited all-time high annual total long term liabilities is $2.43 M

What is Genetic Technologies Limited annual total long term liabilities year-on-year change?

Over the past year, GENE annual total long term liabilities has changed by -$145.20 K (-57.48%)

What is Genetic Technologies Limited quarterly total long term liabilities?

The current quarterly long term liabilities of GENE is $107.40 K

What is the all time high quarterly long term liabilities for Genetic Technologies Limited?

Genetic Technologies Limited all-time high quarterly total long term liabilities is $4.84 M

What is Genetic Technologies Limited quarterly long term liabilities year-on-year change?

Over the past year, GENE quarterly total long term liabilities has changed by -$145.20 K (-57.48%)